Эффективность терапии ХОБЛ у пацентов различных возрастных групп
И. Н. Челенкова, И. И. Трофименко, Утешев Даниил Борисович · Электронный научно-образовательный вестник «Здоровье и образование в XXI веке» · 2010
Now research of efficiency of medicamentous therapy COPD represents an actual problem in connection with a wide circulation of the given pathology among patients of various age. The purpose: to estimate influence of standard therapy COPD at sick various age groups. Materials and methods: retrospective research of stories of illnesses of patients with COPD, arrived on hospitalisation in 2008, 2009 and 2010. Results: 40 stories have been included in research. Middle age on group has made 57,5 ± 3,4 years, from them there were 13 women (32,5 %) at the age of 57,1 ± 3,5 years and 27 men (67,5 %) at the age of 58,2 ± 4,5 years, smokers among women 6 patients (15 %), men 16 persons (40 %). According to the international recommendations [the Global initiative by chronic obstructive illness of lungs Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2003].: a stage I 3 (7 %) a stage II 14 (35 %) a stage III 15 (38 %) a stage IV 8 (20 %). All patients received therapy COPD (prolonged Theophyllinum, Ipratropium bromide, inhalation with the b2-agonists) which remained invariable on all extent of research. Average hospitalization day of patients of all age groups has averaged 15,4 ± 1,2 days. All patients in all age groups and at various stages have been written out with improvement against positive clinic-laboratory dynamics. Conclusions: efficiency of spent complex therapy COPD does not depend on age of the patient.
Cited by 0 works.